Placenta Accreta Spectrum Prophylactic Therapy for Hyperfibrinolysis with Tranexamic Acid.
Tiyasha Hosne AyubBrigitte S StrizekBernd PoetzschPhilipp KosianUlrich GembruchWaltraut M MerzPublished in: Journal of clinical medicine (2023)
Our data support EM as a safe treatment option in PAS. Hyperfibrinolysis can be a cause of hemorrhage during EM and can be treated with TXA. To our knowledge, this is the first cohort of patients with EM of PAS in whom coagulation monitoring and use of TXA have been shown to successfully treat hyperfibrinolysis.